Literature DB >> 27770159

MDCT assessment of resectability in hilar cholangiocarcinoma.

Qihong Ni1, Haolu Wang1,2, Yunhe Zhang1, Lijun Qian3, Jiachang Chi3, Xiaowen Liang2, Tao Chen1, Jian Wang4.   

Abstract

PURPOSE: The purpose of this study is to investigate the value of multidetector computed tomography (MDCT) assessment of resectability in hilar cholangiocarcinoma, and to identify the factors associated with unresectability and accurate evaluation of resectability.
METHODS: From January 2007 to June 2015, a total of 77 consecutive patients were included. All patients had preoperative MDCT (with MPR and MinIP) and surgical treatment, and were pathologically proven with hilar cholangiocarcinoma. The MDCT images were reviewed retrospectively by two senior radiologists and one hepatobiliary surgeon. The surgical findings and pathologic results were considered to be the gold standard. The Chi square test was used to identify factors associated with unresectability and accurate evaluation of resectability.
RESULTS: The sensitivity, specificity, and overall accuracy of MDCT assessment were 83.3 %, 75.9 %, and 80.5 %, respectively. The main causes of inaccuracy were incorrect evaluation of N2 lymph node metastasis (4/15) and distant metastasis (4/15). Bismuth type IV tumor, main or bilateral hepatic artery involvement, and main or bilateral portal vein involvement were highly associated with unresectability (P < 0.001). Patients without biliary drainage had higher accuracy of MDCT evaluation of resectability compared to those with biliary drainage (P < 0.001).
CONCLUSION: MDCT is reliable for preoperative assessment of resectability in hilar cholangiocarcinoma. Bismuth type IV tumor and main or bilateral vascular involvement highly suggest the unresectability of hilar cholangiocarcinoma. Patients without biliary drainage have a more accurate MDCT evaluation of resectability. We suggest MDCT should be performed before biliary drainage to achieve an accurate evaluation of resectability in hilar cholangiocarcinoma.

Entities:  

Keywords:  Hilar cholangiocarcinoma; MDCT; Preoperative evaluation; Resectability

Mesh:

Substances:

Year:  2017        PMID: 27770159     DOI: 10.1007/s00261-016-0943-0

Source DB:  PubMed          Journal:  Abdom Radiol (NY)


  5 in total

1.  Multidetector computed tomography assessment of vascular involvement in perihilar cholangiocarcinoma.

Authors:  Lotte C Franken; Robert J S Coelen; Joris I Erdmann; Joanne Verheij; Marnix P Kop; Thomas M van Gulik; Saffire S Phoa
Journal:  Quant Imaging Med Surg       Date:  2021-11

2.  Transhepatic hilar approach for Bismuth types III and IV perihilar cholangiocarcinoma with long-term outcomes.

Authors:  Xinsen Xu; Linhua Yang; Wei Chen; Min He
Journal:  J Int Med Res       Date:  2021-05       Impact factor: 1.671

Review 3.  Radiologic Evaluation and Structured Reporting Form for Extrahepatic Bile Duct Cancer: 2019 Consensus Recommendations from the Korean Society of Abdominal Radiology.

Authors:  Dong Ho Lee; Bohyun Kim; Eun Sun Lee; Hyoung Jung Kim; Ji Hye Min; Jeong Min Lee; Moon Hyung Choi; Nieun Seo; Sang Hyun Choi; Seong Hyun Kim; Seung Soo Lee; Yang Shin Park; Yong Eun Chung
Journal:  Korean J Radiol       Date:  2020-08-28       Impact factor: 3.500

4.  Predictive model for the intraoperative unresectability of hilar cholangiocarcinoma: Reducing futile surgical exploration.

Authors:  Jinglin Song; Xiaofeng Lei; Heng Lin; Haisu Dai; Xingchao Liu; Yan Jiang; Feng Hu; Yuancheng Li; Haining Fan; Leida Zhang; Zhiyu Chen; Chengcheng Zhang
Journal:  PLoS One       Date:  2022-04-13       Impact factor: 3.240

Review 5.  [Current Status and Recent Update of Imaging Evaluation for Peri-Hilar Cholangiocarcinoma].

Authors:  Dong Ho Lee
Journal:  Taehan Yongsang Uihakhoe Chi       Date:  2021-03-31
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.